Manfred Ahlgrimm
- Co-authors
- Michael PfreundschuhKlaus‐Dieter PreussEvi RegitzJoerg Thomas BittenbringNatalie FadleSandra GraßNiels MurawskiMoritz Bewarder
- Topics
- Monoclonal and Polyclonal Antibodies Research (4 papers)Multiple Myeloma Research and Treatments (3 papers)SARS-CoV-2 and COVID-19 Research (2 papers)
- Cited by
- GeneticsHematologyOncology
- Partner nations
- GermanyUnited StatesGreece
In The Last Decade
Manfred Ahlgrimm
17 papers receiving 264 citations
Peers
Comparison fields: 5 of 57
- Oncology 90
- Molecular Biology 76
- Pathology and Forensic Medicine 58
- Genetics 56
- Immunology 50
Countries citing papers authored by Manfred Ahlgrimm
This map shows the geographic impact of Manfred Ahlgrimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Ahlgrimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Ahlgrimm more than expected).
Fields of papers citing papers by Manfred Ahlgrimm
This network shows the impact of papers produced by Manfred Ahlgrimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Ahlgrimm. The network helps show where Manfred Ahlgrimm may publish in the future.
Co-authorship network of co-authors of Manfred Ahlgrimm
This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Ahlgrimm. A scholar is included among the top collaborators of Manfred Ahlgrimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Ahlgrimm. Manfred Ahlgrimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 25 | |
| 3 | 44 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 48 | |
| 7 | 12 | |
| 8 | 33 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 43 | |
| 13 | 1 | |
| 14 | 40 | |
| 15 | Differentiating between natural progesterone and synthetic progestins: clinical implications for premenstrual syndrome and perimenopause management. | 2 |
| 16 | Differentiating between natural progesterone and synthetic progestogens: clinical implications for premenstrual syndrome management. | 2 |
| 17 | 2 |
About Manfred Ahlgrimm
Manfred Ahlgrimm is a scholar working on Hematology, Oncology and Immunology, having authored 17 papers that have together received 272 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Multiple Myeloma Research and Treatments (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Genetics (56 citations), Hematology (49 citations) and Oncology (90 citations). Manfred Ahlgrimm has collaborated with scholars based in Germany, United States and Greece. Frequent co-authors include Michael Pfreundschuh, Klaus‐Dieter Preuss, Evi Regitz, Joerg Thomas Bittenbring, Natalie Fadle, Sandra Graß, Niels Murawski, Moritz Bewarder, Dominic Kaddu‐Mulindwa and Markus Kreuz. Their work appears in journals such as Blood, The Lancet Oncology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.